Chronic musculoskeletal pain affects millions of Americans, limiting mobility, reducing quality of life and often leading individuals to seek alternatives to surgery or long-term medication use. Among the growing number of integrative treatment options gaining attention is prolotherapy, an injection-based therapy designed to support the body’s natural healing processes. Research suggests that prolotherapy may offer relief for certain chronic pain conditions by targeting weakened or damaged connective tissues. 

Prolotherapy, sometimes referred to as regenerative injection therapy, involves injecting a solution—most commonly hypertonic dextrose, a concentrated sugar solution—into painful ligaments, tendons, joints or fascia. The goal is to stimulate a localized healing response that may encourage tissue repair and reduce pain over time. 

Unlike corticosteroid injections, which are designed to suppress inflammation, prolotherapy works by creating a mild inflammatory response intended to activate healing mechanisms within connective tissue. Researchers believe the therapy may stimulate growth factors, collagen production and tissue remodeling, although experts note that the exact biological mechanisms are still being studied. 

The treatment has been explored for a variety of musculoskeletal conditions, including knee osteoarthritis, plantar fasciitis, chronic low back pain, sacroiliac joint dysfunction and tendinopathies such as tennis elbow. Evidence appears strongest for certain tendon and fascia-related conditions. A 2022 meta-analysis found favorable improvements in pain and function for lateral elbow tendinopathy compared to other nonsurgical treatments. Plantar fasciitis has also demonstrated promising outcomes in several recent reviews. 

However, experts caution that prolotherapy is not a universal cure-all. Research findings remain mixed for some conditions, particularly knee osteoarthritis and chronic low back pain, where studies have shown varying results. The evidence base is complicated by differences in injection techniques, dextrose concentrations, treatment schedules and comparison therapies across studies. 

Still, many patients are drawn to prolotherapy because it offers a minimally invasive option that may help reduce pain while supporting function and mobility. Individuals seeking alternatives to repeated steroid injections, opioid medications or surgery often explore regenerative therapies as part of a broader integrative pain-management plan.

Medical providers emphasize that prolotherapy should be approached thoughtfully and performed by qualified clinicians experienced in musculoskeletal medicine. A thorough evaluation is essential to determine whether a patient is an appropriate candidate and whether other interventions such as physical therapy, strength training or lifestyle modifications should accompany treatment.

For those interested in exploring regenerative therapies, Neurology and Pain Treatment, a Milwaukee-based pain clinic founded by Dr. Neal Pollack, offers prolotherapy as part of its comprehensive approach to chronic pain care. The clinic focuses on individualized treatment strategies designed to help patients improve function and quality of life while addressing the root causes of pain.

As interest in regenerative and integrative medicine continues to grow, prolotherapy remains an area of active research and clinical discussion. While more large-scale studies are needed to clarify its effectiveness across different conditions, current evidence suggests it may provide meaningful relief for select patients seeking a nonsurgical path toward healing and restored mobility.

Neurology & Pain Treatment is located at 2600 N. Mayfair Rd., Ste. 1120, Wauwatosa. For more info or to make an appointment, call 414-453-7780 or visit MilwaukeePainClinic.com.